Related Experiment Video
Updated: Mar 16, 2026

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
Published on: August 2, 2016
Multi-functional vesicles for cancer therapy: The ultimate magic bullet.
Lorena Tavano1, Rita Muzzalupo1
1Department of Pharmacy, Health and Nutritional Sciences, University of Calabria Via Pietro Bucci, Ed. Polifunzionale, 87036 Arcavacata di Rende, Italy.
Multi-functional nanocarriers like liposomes and niosomes offer improved cancer therapy by combining targeting, stimuli-sensitivity, and drug combinations. These advanced drug delivery systems promise enhanced efficacy and reduced side effects for personalized treatments.
Area of Science:
- Nanotechnology
- Biomedical Engineering
- Oncology
Background:
- Chemotherapy faces challenges in selective tumor delivery, causing damage to healthy tissues.
- Current strategies like passive, active, and magnetic targeting, stimuli-sensitive devices, or drug combinations have limitations when used alone.
- Multi-functional approaches represent an evolution beyond traditional 'magic bullet' concepts for improved cancer treatment.
Purpose of the Study:
- To review the potential of multi-functional vesicular nanocarriers for cancer therapy.
- To analyze combinations of targeting strategies, stimuli-sensitivity, and drug combinations in nanocarriers.
- To provide an exhaustive collection of recent investigations on these advanced systems.
Main Methods:
- Focus on liposomes and niosomes as versatile vesicular nanocarriers.
- Analysis of incorporating multiple functionalities into nanocarrier design.
- Review of recent scientific literature on multi-functional nanocarrier applications in cancer therapy.
Main Results:
- Liposomes and niosomes can be engineered for blood longevity, tumor targeting, stimuli-responsiveness, and enhanced intracellular drug delivery.
- Multi-functional vesicular nanocarriers demonstrate significant promise in preclinical and clinical cancer therapy investigations.
- Combinations of targeting, stimuli-sensitivity, and drug strategies enhance therapeutic outcomes.
Conclusions:
- Multi-functional vesicular nanocarriers show broad therapeutic potential for cancer treatment.
- Further development is needed to create more specific and efficient carriers for personalized cancer therapy.
- These advanced nanocarriers are poised to become important therapeutics in the near future.
Related Concept Videos
Intralumenal Vesicles and Multivesicular Bodies
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy
Site-Targeted Drug Delivery Systems: Polymeric Carriers

